LMR Partners’s Dr. Reddy's Laboratories RDY Stock Holding History

LMR Partners’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-162,620	Closed	-$2.39M	–	1270
2024 Q1	$2.39M	Buy	+162,620	New	+$2.37M	0.02%	511
2022 Q2	–	Sell	-201,000	Closed	-$2.27M	–	1434
2022 Q1	$2.27M	Buy	201,000 +155,310	+340%	+$1.76M	0.03%	523
2021 Q4	$602K	Buy	45,690 +7,060	+18%	+$89K	0.01%	858
2021 Q3	$508K	Buy	+38,630	New	+$515K	0.01%	770
2021 Q2	–	Sell	-391,495	Closed	-$4.83M	–	1289
2021 Q1	$4.83M	Buy	391,495 +104,155	+36%	+$1.34M	0.12%	162
2020 Q4	$4.09M	Buy	+287,340	New	+$3.87M	0.06%	119
2017 Q3	–	Sell	-898,000	Closed	-$7.48M	–	502
2017 Q2	$7.48M	Sell	898,000 -277,725	-24%	-$2.26M	0.47%	34
2017 Q1	$9.54M	Buy	1,175,725 +372,725	+46%	+$3.22M	0.92%	25
2016 Q4	$7.24M	Sell	803,000 -305,770	-28%	-$2.85M	1.11%	14
2016 Q3	$10.3M	Buy	+1,108,770	New	+$10.6M	0.98%	15

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LMR Partners's RDY Position: Q2 2024 in Review

LMR Partners sold out of Dr. Reddy's Laboratories (RDY) in Q2 2024, closing a stake of 162,620 shares — an estimated $2.39M sold.

LMR Partners first reported a position in RDY in Q3 2016 and held it in 10 quarters. The position peaked at $10.3M in Q3 2016. 222 funds tracked by Wall St. Rank hold RDY as of Q2 2024.

LMR Partners reported no remaining Dr. Reddy's Laboratories position as of Q2 2024 after selling out during the quarter.
LMR Partners sold 162,620 Dr. Reddy's Laboratories shares in Q2 2024, an estimated $2.39M.
LMR Partners first reported a position in Dr. Reddy's Laboratories in Q3 2016 and held it in 10 quarters.
LMR Partners's Dr. Reddy's Laboratories position peaked at $10.3M in Q3 2016.
222 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2024.

Based on LMR Partners's 13F filing for Q2 2024, filed 14 Aug 2024.